GF
Gary E Friedlaender
Director

Gary E Friedlaender insider trades: Biomimetic Therapeutics (BMTI) stock purchases

Director, Biomimetic Therapeutics Last trade Apr 2, 2012 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2008
1
Company
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gary reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2012BMTI↑ Buy$28K
Mar 19, 2012BMTI↑ Buy$11K
Mar 19, 2012BMTI↑ Buy$11K
Mar 19, 2012BMTI↑ Buy$11K
Jun 25, 2009BMTI↑ Buy$30K
Jun 25, 2009BMTI↑ Buy$27K
Jun 25, 2009BMTI↑ Buy$8K
Jun 25, 2009BMTI↑ Buy$3K
Jun 25, 2009BMTI↑ Buy$2K
Mar 28, 2008BMTI↑ Buy$76K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Gary E Friedlaender's insider trades

Gary E Friedlaender is a director at Biomimetic Therapeutics (BMTI). Since Mar 28, 2008, Gary has reported 10 open-market purchases worth $207K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings), option exercises (5 filings), gifts (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.